Rapid Micro Biosystems (RPID) Expected to Announce Quarterly Earnings on Friday

Rapid Micro Biosystems (NASDAQ:RPID - Get Free Report) will likely be announcing its Q1 2025 earnings results before the market opens on Friday, May 9th. Analysts expect Rapid Micro Biosystems to post earnings of ($0.27) per share and revenue of $6.63 million for the quarter. Rapid Micro Biosystems has set its FY 2025 guidance at EPS.

Rapid Micro Biosystems (NASDAQ:RPID - Get Free Report) last posted its quarterly earnings results on Friday, February 28th. The company reported ($0.22) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.22). The company had revenue of $8.22 million for the quarter, compared to the consensus estimate of $8.20 million. Rapid Micro Biosystems had a negative net margin of 184.93% and a negative return on equity of 48.05%. On average, analysts expect Rapid Micro Biosystems to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Rapid Micro Biosystems Price Performance

RPID stock traded down $0.03 during trading on Wednesday, reaching $2.32. 40,108 shares of the company were exchanged, compared to its average volume of 181,523. The company has a market capitalization of $100.31 million, a price-to-earnings ratio of -2.07 and a beta of 1.12. The company has a 50-day moving average of $2.43 and a two-hundred day moving average of $1.77. Rapid Micro Biosystems has a twelve month low of $0.58 and a twelve month high of $4.04.

Analyst Upgrades and Downgrades

Separately, KeyCorp began coverage on Rapid Micro Biosystems in a research note on Wednesday, February 12th. They issued an "overweight" rating and a $8.00 price target for the company.

About Rapid Micro Biosystems

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.